Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May:137:111295.
doi: 10.1016/j.biopha.2021.111295. Epub 2021 Feb 4.

The emerging roles of IDO2 in cancer and its potential as a therapeutic target

Pengcheng Li  1 , Weiqi Xu  1 , Furong Liu  1 , He Zhu  1 , Lu Zhang  1 , Zeyang Ding  2 , Huifang Liang  3 , Jia Song  4
Affiliations
Free article
Review

The emerging roles of IDO2 in cancer and its potential as a therapeutic target

Pengcheng Li et al. Biomed Pharmacother. 2021 May.
Free article

Abstract

During the past decades, tryptophan metabolism disorder was discovered to play a vital and complex role in the development of cancer. Indoleamine 2,3-dioxygenase 2 (IDO2) is one of the initial and rate-limiting enzymes of the kynurenine pathway of tryptophan catabolism. Increasing evidence indicates that IDO2 is upregulated in some tumors and plays a role in the development of cancer. In spite of the growing body of research, few reviews focused on the role of IDO2 in cancer. Here, we review the emerging knowledge on the roles of IDO2 in cancer and its potential as a therapeutic target. Firstly, the main biological features and regulatory mechanisms are reviewed, after which we focus on the expression and roles of IDO2 in cancer. Finally, we discuss the potential of IDO2 as a therapeutic target for cancer treatment.

Keywords: 2,3-dioxygenase 2/IDO2; Cancer immunotherapy; Indoleamine; Kynurenine pathway; Therapeutic target; Tryptophan metabolism.

PubMed Disclaimer

MeSH terms